amfAR, The Foundation for AIDS Research

A Gene Therapy Revolution

A Gene Therapy Revolution?

New amfAR gene therapy grants awarded as FDA panel recommends approval of first ever gene therapy-based treatment in the U.S.

Why Has Asia Fallen Behind on HIV/AIDS?

Why Has Asia Fallen Behind on HIV/AIDS?

A new TREAT Asia infographic shows a stagnation in HIV program coverage in the Asia-Pacific compared to East and Southern Africa.


amfAR’s Epic Voices

What would a cure mean for the millions of people living with HIV today?


Tracking the Opioid Epidemic

A new amfAR online database provides a window into the deadly opioid epidemic unfolding across every American’s backyard.

Video Stills

Our Research Roadmap

Four key questions that need to be answered in order to achieve a cure.

FF r

Saturday, October 28

Join us in New York City for this fun-filled fundraiser in partnership with the Naked Heart Foundation.


Other News and Features

Breaking Her Silence

We spoke to activist Maria Mejia about her 1991 HIV diagnosis, breaking her silence two decades later, and her passion for human rights and HIV education.

The ACT UP Portraits: Activists & Avatars, 1991-1994

amfAR hosted a special viewing of Stephen Barker’s The ACT-UP Portraits, Activists and Avatars, 1991-1994, at Daniel Cooney Fine Art in New York City. The evening featured remarks by Stephen Barker and a reading by Pulitzer Prize-winning novelist and screenwriter Michael Cunningham.

Living Out Loud: An Interview with Drag Performer Ongina

Drag performer Ongina (born Ryan Ong Palao) made headlines when he disclosed his HIV status on season 1 of RuPaul’s Drag Race.

watch 3
Countdown to a Cure Timepiece

amfAR's Milestone Partner, Harry Winston, Inc., is launching a limited-edition Countdown to a Cure timepiece to benefit the Foundation's efforts to develop a cure for HIV.


Upcoming EventsView All
Past EventsView All

Apply & Participate

  • Harry Winston
  • Bold
  • Delta
  • Kiehls
  • Moet
  • Moncler
  • Audi
  • Renault
  • Cadillac
  • MAC
  • AMTD